QUICK POLL
Microsatellite Instability (MSI-H) in colon cancer has been associated with which of the following?
Clinical Dialogue: Update on Psychopharmacology
March 6 - 7, 2009
New York, New York
Continuing Medical Education
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical educationfor physicians. Imedex, LLC designates this educational activity for a maximum 12.25 of AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Who Should Attend
This educational activity is specifically designed for psychiatrists, psychologists, and other health care practitioners involved or interested in the psychopharmacologic and psychosocial care of patients with psychotic and mood disorders and as well as their co-morbidities.
Objectives
After successful completion of this educational activity, attendees should be able to:
- Review the molecular interaction through which antipsychotic agents elicit their pharmacological effects
- Comment on the role of polypharmacy in schizophrenia
- Outline a therapeutic strategy to overcome refractory psychosis
- Describe treatment approaches that circumvent and/or manage challenging clinical problems associated with psychosis such as substance abuse, violence, and suicide
- Discuss early detection and treatment strategies for first-episode psychosis
- Summarize available and emerging treatment options for schizophrenia
- Discuss the development of novel therapies targeting new molecular pathways in mood disorders
- Summarize available therapeutic options for unipolar and bipolar depression
- Incorporate into clinical practice most favorable treatment modality specific for women that are pregnant or wanting to become pregnant
- Adapt a measurement-based care approach to facilitate individualized patient management based upon dose optimization, disease progression,therapeutic tolerability and sequencing algorithms
- Expand the therapeutic armamentarium for treatment-resistant mood and anxiety disorders including obsessive compulsive disorder and post traumatic stress disorder
Cheryl Corcoran, MD
Columbia University Medical Center
New York, New York
Robert Drake, MD
Dartmouth Medical School
Lebanon, New Hampshire
Donald C. Goff, MD
Massachusetts General Hospital Harvard Medical School
Boston, Massachusetts
Eric Hollander, MD
Mount Sinai School of Medicine
New York, New York
L.Fredrik Jarskog, MD
Lieber Center for Schizophrenia Research & Treatment, New York State Psychiatric Institute
New York, New York
Jeffrey A. Lieberman, MD
Columbia University
New York, New York
Thomas Mellman, MD
Howard University Hospital
Washington, D.C.
Andrew Nierenberg, MD
Massachusetts General Hospital Harvard Medical School
Boston, Massachusetts
Gerard Sanacora, MD, PhD
Yale University School of Medicine
New Haven, Connecticut
David H. Strauss, MD
Columbia University Medical Center
New York, New York
T. Scott Stroup, MD, MPH
University of North Carolina
School of Medicine at Chapel Hill
Chapel Hill, North Carolina
Madhukar Trivedi, MD
University of Texas Southwestern Medical School
Dallas, Texas
Kimberly Yonkers, MD
Yale University School of Medicine
New Haven, Connecticut
Friday, March 6, 2009
Psychosis
8:30 am
Opening remarks
Session I
8:35 am Mechanism of action of antipsychotic drugs
L. Fredrik Jarskog, MD
9:20 am
Antipsychotic polypharmacy for schizophrenia: What is the rationale and state of evidence?
Donald C. Goff, MD
10:05 am
Coffee break
10:30 am
Approaches to refractory symptoms and difficult clinical problems: Suicide, violence, substance abuse
Speaker Invited
11:15 am
Update on psychosocial treatments for schizophrenia
Robert Drake, MD
12:00 pm
Lunch break
Session II
1:00 pm
Roundtable discussion: Management of antipsychotic drug side effects
Donald C. Goff, MD, T. Scott Stroup, MD, MPH, Speaker Invited
1:45 pm
What’s new regarding the prodrome and first-episode psychosis?
Cheryl Corcoran, MD
2:30 pm Coffee break
2:55 pm
Update on emerging treatments for schizophrenia
Jeffrey A. Lieberman, MD
3:40 pm
Ask the expert: Panel discussion
Moderators: Jeffrey A. Lieberman, MD and T. Scott Stroup, MD, MPH
4:30 pm
Adjourn
Saturday, March 7, 2009
Mood Disorders
8:30 am
Opening remarks
Madhukar Trivedi, MD
Session III
8:35 am
New targets/new treatments for mood disorders: The role GABA and glutamate in MDD
Gerard Sanacora, MD, PhD
9:20 am
Evidence-based treatment for unipolar and bipolar depression: What are the options?
Andrew Nierenberg, MD
10:05 am
Coffee break
10:30 am
Managing mood disorders in and following pregnancy
Kimberly Yonkers, MD
11:15 am
Roundtable discussion: Case-based discussions of treatment-resistant mood and anxiety disorders
Moderated by: Andrew Nierenberg, MD, Gerard Sanacora, MD, PhD, Kimberly Yonkers, MD
12:00 pm
Lunch break
Session IV
1:00 pm
Treatment options for post traumatic stress disorder
Thomas Mellman, MD
1:45 pm
Measurement-based care: Why? How? To what effect?
Madhukar Trivedi, MD
2:30 pm
Coffee break
2:55 pm
Treatment options for obsessive compulsive disorder
Eric Hollander, MD
3:40 pm Ask the expert: Panel discussion
Moderated by: Eric Hollander, MD, Thomas Mellman, MD, Madhukar Trivedi, MD
4:30 pm
Adjourn
Registration Fees
Regular . . . . . . . . . . . . . . .$125
If payment received by February 26, 2009
Full/Onsite. . . . . . . . . . . . . . .$150
If payment received after February 26, 2009
To Register: You may register online by February 26, 2009, by calling Imedex at +1 (678) 242 0906 or by returning the registration form in this announcement by mail or fax. If you mail the form, please keep a copy for your records. Registration confirmations will be issued before the meeting. To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.
Payment: To pre-register, registration and payment must be received no later than February 26, 2009. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the course is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card or check. Checks should be payable to Imedex. Attendee is not registered until full payment is received.
Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, conference materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the announcement.
Cancellation: For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than February 26, 2009. The amount of registration fees remitted, minus a $75 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after February 26, 2009.
Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.
InterContinental The Barclay New York
111 East 48th Street
New York, New York 10017
Tel.: + 1 (212) 755 5900
Fax: +1 (212) 644 0079
new-york-barclay.intercontinental.com
Restored to its 1926 neo-Federal style, InterContinental The Barclay New York welcomes guests with residential warmth and luxury. Few hotels provide such easy access to must-see attractions including Rockefeller Center, Carnegie Hall, The Metropolitan Museum of Art, Times Square and Central Park. The Statue of Liberty is a short taxi ride away.
For the convenience of attendees, a limited number of rooms have been reserved until February 12, 2009 at a discounted rate of $309 single/double occupancy, plus tax, currently at 13.375%. This rate is not guaranteed outside the conference dates or after February 12, 2009. To reserve your room please contact the InterContinental The Barclay New York reservations department at + 1 (212) 755 5900 or visit the hotel’s website at new-york-barclay.intercontinental.com.
To receive the group rate, callers must identify themselves as being with the Clinical Dialogue: Update on Psychopharmacology group. Internet users must enter the meeting promotional code: IMEDEX08. Reservation requests received after February 12, 2009 may not be guaranteed the group rate.
Chairs:
Jeffrey A. Lieberman, MD
Columbia University
New York, New York
T. Scott Stroup, MD, MPH
University of North Carolina
School of Medicine at Chapel Hill
Chapel Hill, North Carolina
Madhukar Trivedi, MD
University of Texas Southwestern Medical School
Dallas, Texas
Letter from the Chairs
DEAR COLLEAGUES,
It is with great pleasure that we invite you to participate in the 2009 Clinical Dialogue: Update on Psychopharmacology. This educational conference will focus on a variety of topics ranging from prodrome and first-episode psychosis to new treatments for mood disorders and schizophrenia.
This conference will provide you with the opportunity to enhance your knowledge on new and upcoming management techniques and treatments.
We received great feedback on the level of audience participation at last year’s meeting, so we will continue to offer expert panel and clinical case discussions.
We look forward to sharing this essential clinical information with you at this important educational forum. We encourage you to register early to guarantee your seat!
Sincerely,
Jeffrey A. Lieberman, MD
T. Scott Stroup, MD, MPH
Madhukar Trivedi, MD
Discounted Airfares
Contact Congress travel agent, Williamsburg Travel, for assistance with your travel needs.
Williamsburg Travel can also accommodate pre- and post-Congress extensions.
Tel.: +1 (888) 232-9394 or +1 (770) 261-8613
Email: judit@willtrav.com
Conference Location and Registration
InterContinental The Barclay New York
111 East 48th Street
New York, New York 10017
Tel.: + 1 (212) 755 5900
Fax: +1 (212) 644 0079
new-york-barclay.intercontinental.com
The Registration and Information Desk will be staffed:
Friday, March 6, 2009. . . . . . . . . . . . . . .8:00 am – 4:30 pm
Saturday, March 7, 2009. . . . . . . . . . . . .8:00 am – 4:30 pm
ORGANIZER
Imedex
4325 Alexander Drive
Alpharetta, GA 30022-3740 USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
Content Advisor
Arlene Kagle, PhD
Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2008 Imedex®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
The following companies have provided educational grants in support of this conference:
PLATINUM
SILVER
BRONZE
Several options are available to companies interested in supporting this conference. For more information, please contact Imedex at +1(770) 751 7332, or by email at cme@imedex.com.